Stop STALLING Act

The Stop STALLING Act aims to lower prescription drug costs by preventing pharmaceutical companies from filing baseless petitions with the Food and Drug Administration (FDA) to delay the approval of cheaper generic alternatives. This bill authorizes the Federal Trade Commission to sue and fine companies that use these "sham" filings to block competition and keep drug prices high. By streamlining the approval process for generic medications, the legislation seeks to help consumers access more affordable healthcare options more quickly.